down arrow

Vitrolife AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0011205202
SEK
90.00
1.2 (1.35%)

Aug 07

OME

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Getinge AB
BONESUPPORT HOLDING AB
Xvivo Perfusion AB
MedCap AB
Surgical Science Sweden AB
CellaVision AB
Biotage AB
Vitrolife AB
Bactiguard Holding AB
Genovis AB
Elekta AB

Why is Vitrolife AB ?

1
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -34.07%, its profits have fallen by -21.9%
2
Below par performance in long term as well as near term
  • Along with generating -34.07% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Vitrolife AB for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Vitrolife AB
-34.07%
-1.22
40.76%
OMX Stockholm 30
27.7%
1.79
15.50%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
22.52%
EBIT Growth (5y)
10.99%
EBIT to Interest (avg)
10.39
Debt to EBITDA (avg)
1.20
Net Debt to Equity (avg)
0.06
Sales to Capital Employed (avg)
0.27
Tax Ratio
2.72%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
4.96%
ROE (avg)
5.51%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
35
Industry P/E
Price to Book Value
1.75
EV to EBIT
24.69
EV to EBITDA
14.44
EV to Capital Employed
1.70
EV to Sales
4.33
PEG Ratio
NA
Dividend Yield
1.05%
ROCE (Latest)
6.88%
ROE (Latest)
4.97%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -4.71% (YoY

OPERATING PROFIT(Q)

Highest at SEK 286 MM

OPERATING PROFIT MARGIN(Q)

Highest at 33.37 %

PRE-TAX PROFIT(Q)

Highest at SEK 179 MM

NET PROFIT(Q)

Highest at SEK 129 MM

EPS(Q)

Highest at SEK 0.95

-5What is not working for the Company
INTEREST(HY)

At SEK 38 MM has Grown at 153.33%

INVENTORY TURNOVER RATIO(HY)

Lowest at 3.74 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.24 times

Here's what is working for Vitrolife AB

Operating Profit
Highest at SEK 286 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (SEK MM)

Operating Profit Margin
Highest at 33.37 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at SEK 179 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (SEK MM)

Pre-Tax Profit
At SEK 179 MM has Grown at 39.03%
over average net sales of the previous four periods of SEK 128.75 MM
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (SEK MM)

Net Profit
Highest at SEK 129 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (SEK MM)

EPS
Highest at SEK 0.95
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (SEK)

Raw Material Cost
Fallen by -4.71% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Vitrolife AB

Interest
At SEK 38 MM has Grown at 153.33%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Inventory Turnover Ratio
Lowest at 3.74 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio
Lowest at 4.24 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."